Short description
ImmuCision Biotherapeutics develops immunotherapy technologies for cancer treatment.
Description
ImmuCision Biotherapeutics focuses on the research and clinical development of immune cell-based therapies for human cancer. They are the development of cell-based immunotherapy for human cancer. They utilizes an innovative dendritic cell technology to generate cancer-fighting tumor antigen and natural killer cells.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Baltimore, Maryland, United States, North America
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Founders
Hua Cheng